ArticleClinical and experimental immunology2006

A form of circulating interleukin-6 receptor component soluble gp130 as a potential interleukin-6 inhibitor in inflammatory bowel disease.

K Mitsuyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.